Brief: Qualigen Therapeutics, Inc. Received Nasdaq Notice Of A Delisting Determination
30/05/2024 22:22
Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. RECEIVED NASDAQ NOTICE OF A
DELISTING DETERMINATION
Source text for Eikon: ID:nGNX64rCsm
Further company coverage: QLGN.O
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise